Taylor and Francis Ltd. provides LaTeX templates for many of its journals. Check this journal’s author guidelines, and we can convert your manuscript into its template.
LaTeX Template Conversion →Journals listed in Web of Science and JCR receive many submissions and desk reject a large share. A section-by-section audit by a PhD reviewer in your area shows what to fix first.
Manuscript Auditing →01Impact factor
Impact factor of Neurodegenerative Disease Management (2026)
The impact factor shown here is the 2-year mean citedness: citations received in a year by the papers Neurodegenerative Disease Management published in the two previous years, divided by the number of those papers. That is the same formula as the Journal Impact Factor, applied to the open citation data of OpenAlex. The journal is listed in JCR 2024, so it also has an official Journal Impact Factor published by Clarivate, which can differ because it counts citations from Web of Science journals only.
Rank in its subject categories
- Clinical Neurologyrank 156 of 297 journals
Ranks here compare journals of the same Web of Science category in our data by 2-year citedness; they are not the official JCR rank.
Quartile of Neurodegenerative Disease Management
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Neurodegenerative Disease Management is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Citations and papers per year
02Review time
Review time of Neurodegenerative Disease Management
Each paper took a different time. The green box holds the middle half of the papers and the dark line is the median; the whiskers reach the fastest 10% and the slowest 10%. Plan with the whole spread, not only the median.
Half of the research articles Neurodegenerative Disease Management published between Nov 2024 and Oct 2026 were accepted within 126 days of submission, and the middle half took between 92 and 173 days. This time includes peer review and any revision rounds. Papers that were rejected are not counted, because only published papers carry these dates.
In Clinical Neurology, Neurodegenerative Disease Management ranks 79 of 121 journals by review time (1 = fastest). See the fastest-review journals in Clinical Neurology →
03Fee waivers
APC waivers and discounts for Neurodegenerative Disease Management
Neurodegenerative Disease Management follows the waiver policy of its publisher, Taylor & Francis: 100% waiver for low-income and 50% for lower-middle income countries (World Bank list with a GDP limit), on request. Only the corresponding author's affiliation counts. Co-authors from other countries do not change the waiver.
Authors affiliated in 24 countries qualify for a full waiver. See the countries →
Waivers apply to fully open access journals. If Neurodegenerative Disease Management is a hybrid journal, you can publish without any fee through the subscription route.
Checking the waiver rules for your country…
Who funds research published in Neurodegenerative Disease Management
Funders named most often
A high share of funded papers usually means the journal is a common choice for grant-supported work in its field. If your funder pays article processing charges, or your country qualifies for a waiver, check what applies to your author team with the free APC waiver checker.
Submitting to Neurodegenerative Disease Management? See your rejection risk first.
Seven questions our reviewers ask in every audit, plus your abstract and the fit with this journal. Free, no sign-up, about 2 minutes.
04Indexing
Indexing of Neurodegenerative Disease Management
- ISSN
- 1758-2024
- eISSN
- 1758-2032
- Publisher
- Taylor and Francis Ltd. all its journals →
- Country
- England
- Language
- English
- Scopus source type
- Journal
- Web of Science categories
- Clinical Neurology
From the indexing lists used on ScholarsColab, updated 1 March 2026. Indexing can change: confirm on the Web of Science Master Journal List or the Scopus source list before submitting. Official Journal Impact Factors and JCR quartiles are published by Clarivate; the impact factor and quartile on this page are calculated from OpenAlex open data (see how the impact factor works).
Each link opens the official record for this journal, searched by its ISSN where we have one.
05How to submit
How to submit to Neurodegenerative Disease Management
- Read the guide for authors. It sets the article types, word limit, reference style and file format that Neurodegenerative Disease Management accepts. You find it on the official website of the journal, usually under "For authors" or "Submit".
- Use the journal's template. Taylor and Francis Ltd. offers Word and LaTeX templates for many of its journals. If your manuscript is in Word and the journal wants LaTeX, our LaTeX Template Conversion moves it into the template.
- Check the fit. Read the aims and scope and a few recent issues; papers outside the scope are the most common reason for a desk rejection. The Journal Finder shows journals that published the closest work.
- Check the fee. Neurodegenerative Disease Management is not a fully open access journal, so authors usually pay nothing unless they choose open access for their article or the journal charges page or colour fees. The guide for authors states the current charges.
- Check your manuscript before you submit. The free Submission Readiness Check asks the seven questions our reviewers ask in every audit and takes about 2 minutes.
06Reviewer comments
Reviewer comments and rejection reasons for Neurodegenerative Disease Management
No reviewer or editor comments have been shared for this journal yet. Did you submit here? Help other researchers by sharing the comments you received, anonymously.
Share reviewer comments for this journal →Across the reviewer comments researchers have shared with us, the points raised most often are figures, tables and equations (21%), literature and references (12%) and novelty and contribution (10%). Before you submit to Neurodegenerative Disease Management, a Manuscript Audit by a PhD reviewer in your area checks your paper against exactly these points.
Audit my paper before I submit →Not sure yet? Check if your paper is ready for this journal: free, no AI, under 5 secondsPreparing to submit here? Make sure reviewers don't stop at the issues they raise most often. A PhD reviewer in your area can audit your manuscript section by section, and we can convert it into the journal's LaTeX template.
07Same subject
Clinical Neurology journals with a similar impact factor*
The journals next to Neurodegenerative Disease Management when the 286 journals of Clinical Neurology in our data are ranked by impact factor*:
| Rank | Journal | Impact factor* | Indexing | Open access |
|---|---|---|---|---|
| 152 | Journal of Clinical Neurophysiology | 1.86 | SCIE | Subscription |
| 153 | Brain Impairment | 1.85 | SCIE | Subscription |
| 154 | Tremor and Other Hyperkinetic Movements | 1.85 | ESCI | Fully open access |
| 155 | Neuro-Oncology Practice | 1.85 | ESCI | Subscription |
| 157 | Spine Deformity | 1.84 | ESCI | Subscription |
| 158 | Neurosciences | 1.84 | SCIE | Some open access |
| 159 | Neurology Report | 1.81 | SCIE | Subscription |
| 160 | Journal of Neurosurgery Pediatrics | 1.81 | SCIE | Subscription |
*Impact factor calculated from OpenAlex open data (2-year citedness), not the official Clarivate value.
08Journal Finder
Find the right journal for your paper
Is Neurodegenerative Disease Management right for your paper? Compare journals
Paste your title, keywords or abstract. See the journals that published the closest papers, with indexing, impact factor, review time and APC.
No AI or language model is used. Your words are matched against the titles of 156,503 real published journal papers, by our mentors and by other researchers (shown without names); journals are ranked by how many closely matching papers they published. Indexing comes from the SCIE, SSCI, AHCI, ESCI, Scopus and JCR 2024 lists, matched by journal name; the impact factor is calculated from OpenAlex open data, not the official Clarivate value, and no quartile is shown until the official JCR or SJR quartile can be; review time comes from the dates publishers deposit in Crossref (not every publisher deposits them). Always check a journal’s scope and current indexing before submitting.
09Questions
Frequently asked questions
How long is the review time of Neurodegenerative Disease Management?
Based on 163 research articles Neurodegenerative Disease Management published from Nov 2024 to Oct 2026, the median time from submission to acceptance was 126 days, and half of them were accepted between 92 and 173 days. After acceptance, papers appeared online after a median of 13 days. Source: received and accepted dates deposited by the publisher in Crossref, retrieved October 2026. Individual papers can take longer, especially with major revisions.
What is the impact factor of Neurodegenerative Disease Management?
Based on OpenAlex citation data (October 2026), the 2-year impact factor of Neurodegenerative Disease Management is 1.84: papers it published in the two previous years were cited 1.84 times on average in a year. The journal is listed in JCR 2024, so Clarivate also publishes an official Journal Impact Factor, which can differ.
What is the h-index of Neurodegenerative Disease Management?
The h-index of Neurodegenerative Disease Management is 47 (OpenAlex, October 2026): 47 of its papers have each been cited at least 47 times. Its i10-index is 292.
What is the quartile of Neurodegenerative Disease Management?
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Neurodegenerative Disease Management is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Is Neurodegenerative Disease Management indexed in Scopus?
Yes. Neurodegenerative Disease Management appears in the Scopus list, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Neurodegenerative Disease Management an SCIE journal?
Neurodegenerative Disease Management is listed in ESCI of the Web of Science Core Collection, but not in SCIE, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Neurodegenerative Disease Management in Journal Citation Reports (JCR)?
Yes. Neurodegenerative Disease Management is listed in JCR 2024, so it has a Journal Impact Factor. For the current impact factor and quartile, check Journal Citation Reports.
Does Neurodegenerative Disease Management offer an APC waiver?
Neurodegenerative Disease Management follows the policy of Taylor & Francis: 100% waiver for low-income and 50% for lower-middle income countries (World Bank list with a GDP limit), on request. Only the corresponding author's affiliation counts. Co-authors from other countries do not change the waiver. Rules verified 27 October 2026; confirm on the publisher's page.
Who funds research published in Neurodegenerative Disease Management?
40% of 166 recent research articles in Neurodegenerative Disease Management name a funder in Crossref; the funders named most often are National Natural Science Foundation of China, National Council for Scientific and Technological Development, Novo Nordisk Inc.
Want a PhD expert to choose the journal with you?
Our Journal Selection & Submission service shortlists up to 5 journals that match your manuscript, indexing requirement and target quartile, and handles the submission. If your paper was rejected before, a Manuscript Audit shows what to fix first.
Not sure yet? Check your manuscript for this journal, free · How the process works
Popular journals
- The Lancet
- Nature
- Science
- PLoS ONE
- Scientific Reports
- Journal of the American Chemical Society
- Frontiers in Immunology
- Cancer Research
- Alzheimer's and Dementia
- Tetrahedron
- Journal of Bacteriology
- Medical Physics
- Chemical Physics Letters
- Materials Science and Engineering: A
- Food Chemistry
- Applied Optics
- Journal of Physical Chemistry A
- Construction and Building Materials
- Investigative Ophthalmology and Visual Science
- IEEE Transactions on Magnetics
Browse all journals: indexing, impact factor and reviewer comments →